Allogeneic mitochondrial transplantation ameliorates cardiac dysfunction due to doxorubicin: An in vivo study

Allogeneic mitochondrial transplantation ameliorates cardiac dysfunction due to doxorubicin: An in vivo study

Damage to the mitochondria may lead to serious conditions that are difficult to treat. Doxorubicin is one of the most widely used chemotherapeutic drugs for the treatment of malignancies in children and adults, and reportedly causes damage to the mitochondria. Unfortunately, the dangerous cardiac si...

Full description

Bibliographic Details
Main Authors: Farshid Maleki, Shahram Rabbani, Reza Shirkoohi, Mohsen Rezaei
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Mitochondrial transplantation
Doxorubicin
Cardiotoxicity
Oxidative stress
Chemotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S075333222301449X

Internet

http://www.sciencedirect.com/science/article/pii/S075333222301449X

Similar Items